Cengild Medical BhdXKLS:0243 -2.50%66 PS Ratio is 2.24 as of Jul. 08, 2026, which is 41% below its 10-year median of 3.80. GuruFocus rates XKLS:0243 with a GF Score™ of 66/100 and a GF Value™ of RM0.29 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Cengild Medical Bhd ranks worse than 62.1% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Cengild Medical Bhd's share price is RM0.195.
Cengild Medical Bhd's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was RM0.09. Hence, Cengild Medical Bhd's PS Ratio for today is 2.24.
Good Sign:
Cengild Medical Bhd stock PS Ratio (=2.24) is close to 5-year low of 2.24.
The historical rank and industry rank for Cengild Medical Bhd's PS Ratio or its related term are showing as below:
XKLS:0243'
s PS Ratio Range Over the Past 10 Years
Min: 2.24 Med: 3.8 Max: 8.79
Current: 2.24
During the past 8 years, Cengild Medical Bhd's highest PS Ratio was 8.79. The lowest was 2.24. And the median was 3.80.
XKLS:0243's PS Ratio is ranked worse than 62.1% of 657
companies
in the Healthcare Providers & Services industry
Industry Median: 1.5
vs XKLS:0243: 2.24
Cengild Medical Bhd revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Cengild Medical Bhd was -5.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -1.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 10.10% per year.
During the past 8 years, Cengild Medical Bhd's highest 3-Year average Revenue per Share Growth Rate was 77.30% per year. The lowest was -1.40% per year. And the median was 21.00% per year.
Back to Basics: PS Ratio
Cengild Medical Bhd (XKLS:0243) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Cengild Medical Bhd PS Ratio Related Terms
Cengild Medical Bhd PS Ratio Historical Data
* Premium members only.
The historical data trend for Cengild Medical Bhd's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Cengild Medical Bhd's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cengild Medical Bhd PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cengild Medical Bhd's PS Ratio distribution charts can be found below:
* The bar in red indicates where Cengild Medical Bhd's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Cengild Medical Bhd's Share Price of today is RM0.195. Cengild Medical Bhd's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.09.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Cengild Medical Bhd (XKLS:0243) has a PS Ratio of 2.24 as of Jul. 08, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Cengild Medical Bhd and its competitors. This is 41% below median its historical median of 3.80. Over the past decade, Cengild Medical Bhd's PS Ratio has ranged from 2.24 to 8.79. According to the industry distribution chart, Cengild Medical Bhd ranks #408 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 62.1%.
Is Cengild Medical Bhd's PS Ratio too high?
Cengild Medical Bhd's current PS Ratio of 2.24 is 41% below median its 10-year median of 3.80. Over the past 10 years, this metric has ranged from a low of 2.24 to a high of 8.79. The Healthcare Providers & Services industry median PS Ratio is 1.50. Cengild Medical Bhd's value of 2.24 is 49.3% above this industry median. Based on the distribution chart, Cengild Medical Bhd ranks #408 out of 657 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Cengild Medical Bhd has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cengild Medical Bhd's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Cengild Medical Bhd ranks #408 out of 657 companies for PS Ratio. This places Cengild Medical Bhd in the lower half of its industry. The industry median PS Ratio is 1.50. Cengild Medical Bhd's value of 2.24 is 49.3% above this benchmark. Historically, Cengild Medical Bhd's own PS Ratio has ranged from 2.24 to 8.79 over the past decade. While the company's 10-year median is 3.80 vs. the industry median of 1.50, Cengild Medical Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.50, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cengild Medical Bhd's current PS Ratio of 2.24 is 49.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Cengild Medical Bhd and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cengild Medical Bhd's current PS Ratio is 2.24, which is 41% below median its own 10-year median of 3.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cengild Medical Bhd stock overvalued right now?
Based on GuruFocus' analysis, Cengild Medical Bhd (XKLS:0243) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.29, compared to a current price of RM0.20 — trading 32.8% below its estimated fair value. The current PS Ratio is 2.24, which is 41% below median its 10-year median of 3.80 and 49.3% above the Healthcare Providers & Services industry median of 1.50. Cengild Medical Bhd's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Cengild Medical Bhd (XKLS:0243), the current PS Ratio is 2.24 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cengild Medical Bhd (XKLS:0243) Overvalued in 2026?
Based on GuruFocus' analysis, Cengild Medical Bhd stock appears to be undervalued.
The current stock price of RM0.20 is trading 32.8% below its estimated GF Value™ of RM0.29.
GuruFocus considers Cengild Medical Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:0243:
PS Ratio: 2.24 (41% below median its 10-year median of 3.80)
GF Value™: RM0.29 vs. price of RM0.20 (32.8% below fair value)
Industry Position: 49.3% above the Healthcare Providers & Services median (#408 of 657)
No single metric tells the full story. See the XKLS:0243 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
66GF Score
Get the complete analysis for XKLS:0243
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0243 has been successfully added to your 
